Infection in the neuroischemic foot

International Journal of Lower Extremity Wounds

Volumn 4, Issue 3, 2005, Pages 145-153

  Edmonds, Michael ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Amputation; Diabetic foot disease; Infection; Ischemia; Neuroischemia; Neuropathy

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMOXYL; ANTIBIOTIC AGENT; CEFALEXIN; CEFTAZIDIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDATE SODIUM; INSULIN; LIDOCAINE; LINEZOLID; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; PSEUDOMONIC ACID; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; TRIMETHOPRIM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; CELLULITIS; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; FOOT AMPUTATION; FOOT ULCER; HUMAN; INFECTION; INSULIN TREATMENT; LIMB ISCHEMIA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE NECROSIS; AMPUTATION; BACTERIAL INFECTION; DEBRIDEMENT; DISEASE COURSE; PROGNOSIS;

AMPUTATION; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DEBRIDEMENT; DIABETIC FOOT; DISEASE PROGRESSION; HUMANS; PROGNOSIS;

EID: 26044455392     PISSN: 15347346     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534734605280597     Document Type: Review

References (49)

1. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1999;22:1354-60.
2. International Working Group on the Diabetic Foot. International consensus on the diabetic foot [CD-ROM]. Brussels, Belgium: International Diabetes Federation; 2003.
3. Sato N, Shimizu H, Suwa K, Shimomura Y, Kobayashi I, Mori M. MPO activity and generation of active O2 species in leukocytes from poorly controlled diabetic patients. Diabetes Care 1992;15:1050-2.
4. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus DM. FEMS Immunol Med Microbiol 1999;3-4:259-65.
5. Leibovici L, Yehezkelli Y, Porter A, Regev A, Krauze I, Harell D. Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections. Diabet Med 1996;13: 457-63.
6. Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992;15:256-60.
7. Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JH. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990;150:790-7.
8. Abdulrazak A, Bitar ZI, Al-Shamali AA, Mobasher LA. Bacteriological study of diabetic foot infections. J Diabetes Complicat 2005;193:138-41.
9. Hampton E, Edmonds ME. Microbiology is different in the foot infections of the neuro-ischaemic foot compared with the neuropathic foot. Diabet Med 2004;21 Suppl II:P268.
10. Tentolouris N, Jude EB, Smirnof I, Knowles EA, Boulton AJ. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 1999;16:767-71.
11. Dang CN, Prasad YD, Boulton AJ, Jude EB. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 2003;20:159-61.
12. Phelan RA, Edmonds ME. Improvement in the transcutaneous oxygen tension by treatment of infection in the ischaemic diabetic foot. Diabet Med 2005;22 Suppl II:P230.
13. Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med 1987;318:1306-9.
14. Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg 1996;35:280-3.
15. Edmonds ME, Foster AVM. Infections complicating diseases of the feet in renal patients. In: Sweny P, Rubin R, Tolkoff-Rubin N, editors. The infectious complications of renal disease. New York: Oxford University Press; 2003. p. 399-416.
16. Armstrong DG, Lavery LA, Quebedeaux TL, Walker SC. Surgical morbidity and the risk of amputation due to infected puncture wounds in diabetic versus nondiabetic adults. South Med J 1997;904: 384-9.
17. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers: a clinical sign of osteomyelitis in diabetic patients. JAMA 1995;273:721-3.
18. Craig JG, Amin MB, Wu K, Eyler WR, van Holsbeeck MT, Bouffard JA, et al. Osteomyelitis of the diabetic foot: MR imaging-pathological correlation. Radiology 1998;203:849-55.
19. Morrison WB, Schweitzer ME, Batte WG, Radack DP, Russel KM. Osteomyelitis of the foot: relative importance of primary and secondary MR imaging signs. Radiology 1998;207:625-32.
20. Enderle MD, Coerper S, Schweizer HP, Kopp AE, Thelen MH, Meisner C, et al. Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. Diabetes Care 1999;22:294-9.
21. Rajbhandari SM, Sutton M, Davies C, Tesfaye S, Ward JD. "Sausage toe": a reliable sign of underlying osteomyelitis. Diabet Med 2000;17:74-7.
22. Edmonds ME, Foster AVM. Managing the diabetic foot. Oxford: Blackwell Science; 2000.
23. Pellizzer G, Strazzabosco M, Presi S, Furlan F, Lora L, Benedetti P, et al. Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med 2001;18:822-7.
24. Chantelau E, Tanudjaja T, Altenhofer F, Ersanili Z, Lacigova S, Metzger C. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Diabet Med 1996;13:156-9.
25. Grayson ML. Diabetic foot infections: antimicrobial therapy. In: Eliopoulos GM, editor. Infectious disease clinics of North America. Philadelphia: WB Saunders; 1995. p. 143-62.
26. Harkless L, Boghossian J, Pollak R, Caputo W, Dana A, Gray S, et al. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surg Infect (Larchmt) 2005;61:27-40.
27. Edmonds ME, Foster AVM, Sanders LJ. A practical manual of diabetic foot care. Oxford: Blackwell; 2004.
28. Anstead GM, Owens AD. Recent advances in the treatment of infections due to resistant Staphylococcus aureus. Curr Opin Infect Dis 2004;176:549-55.
29. Lipsky BA, Itani K, Norden C, Linezolid Diabetic Foot Infections Study Group. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin- clavulanate. Clin Infect Dis 2004;38:17-24.
30. Venkatesan P, Lawn S, Macfarlane RM, Fletcher EM, Finch RG, Jeffcoate WJ. Conservative management of osteomyelitis in the feet of diabetic patients. Diabet Med 1997;14:487-90.
31. Gough A, Clapperton M, Rolando N, Foster AV, Philpott-Howard J, Edmonds ME. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet 1997;350: 855-9.
32. Cruciani M, Lipsky BA, Mengoli C, de Lalla F. Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections? A meta-analysis. Diabetes Care 2005;28:454-60.
33. Bakker DJ. Hyperbaric oxygen therapy and the diabetic foot. Diabetes Metab Res Rev 2000;16 Suppl 1:S55-8.
34. Clare MP, Fitzgibbons TC, McMullen ST, Stice RC, Hayes DF, Henkel L. Experience with the vacuum assisted closure negative pressure technique in the treatment of non-healing diabetic and dysvascular wounds. Foot Ankle Int 2002;2310:896-901.
35. Vermassen FE, van Landuyt K. Combined vascular reconstruction and free flap transfer in diabetic arterial disease. Diabetes Metab Res Rev 2000;1:S33-6.
36. Pomposelli FB, Kansal N, Hamdan AD, Belfield A, Sheahan M, Campbell DR, et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003;372:307-15.
37. McArthur CS, Sheahan MG, Pomposelli FB Jr, Dayko A, Belfield AK, Veraldi J, et al. Infrainguinal revascularization after renal transplantation. J Vasc Surg 2003;376:1181-5.
38. Ramdev P, Rayan SS, Sheahan M, Hamdan AD, Logerfo FW, Akbari CM, et al. A decade experience with infrainguinal revascularization in a dialysis-dependent patient population. J Vasc Surg 2002; 365:969-74.
39. Treiman GS, Lawrence PF, Rockwell WB. Autogenous arterial bypass grafts: durable patency and limb salvage in patients with inframalleolar occlusive disease and end-stage renal disease. J Vasc Surg 2000;321:13-22.
40. Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002;2523:225-32.
41. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341:1789-94.
42. Fleisher LA, Eagle KA. Screening for cardiac disease in patients having noncardiac surgery. Ann Intern Med 1996;124:767-72.
43. Hood DB, Weaver FA, Papanicolaou G, Wadhwani A, Yellin AE. Cardiac evaluation of the diabetic patients prior to peripheral vascular surgery. Ann Vasc Surg 1996;10:330-5.
44. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, et al. Guidelines for perioperative cardiovascular evaluation for non cardiac surgery: an abridged version of the report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Mayo Clin Proc 1997;524-31.
45. Karchmer AW. Microbiology and treatment of diabetic foot infections. In: Veves A, Giurini JM, LoGerfo FW, editors. The diabetic foot: medical and surgical management. Totowa (NJ): Humana Press; 2002. p. 207-19.
46. Larsson J, Apelqvist J, Agardh CD, Stenstrom A. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabet Med 1995;129: 770-6.
47. Holstein P, Ellitsgaard N, Olsen BB, Ellitsgaard V. Decreasing incidence of major amputations in people with diabetes. Diabetologia 2000;437:844-7.
48. Faglia E, Favales F, Aldeghi A, Calia P, Quarantiello A, Barbano P, et al. Change in major imputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation. J Diabetes Complicat 1998;122:96-102.
49. Edmonds M, Foster AVM. Reduction of major amputations in the diabetic ischemic foot: a strategy to "take control" with conservative care as well as revascularisation. VASA 2001;58 Suppl:6-14.